IPP Bureau
Cadila Pharmaceuticals opens advanced pharmaceutical warehouse
By IPP Bureau - February 26, 2025
FDA grants EUA to Aptitude’s Covid/flu multiplex test for OTC use
By IPP Bureau - February 26, 2025
Amgen opens new technology and innovation site in Hyderabad
By IPP Bureau - February 25, 2025
Amgen India investment totals $200 million through 2025
Biocon Biologics launches Yesintek Biosimilar to Stelara in US
By IPP Bureau - February 25, 2025
YESINTEK is approved for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis
Indegene launches AI platform Cortex
By IPP Bureau - February 25, 2025
This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain
Teva and Sanofi present new outcome from Phase 2b study of duvakitug
By IPP Bureau - February 25, 2025
Findings to form the basis for a Phase 3 program, anticipated to start in H2 2025
.JPG "Somaiya Vidyavihar University hosts conference on ‘Clinical Translation of Biomaterials for Future Healthcare’")
Briefs: Syngene International and Cipla
By IPP Bureau - February 23, 2025
Cipla Limited has received final approval from the USFDA for the New Drug Application submitted for ‘Nilotinib Capsules 50, 150 and 200 mg’
Sandeep Rao appointed MD and CEO of Solar Active Pharma Sciences
By IPP Bureau - February 23, 2025
Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
5.1 lakh TB patients notified across India
By IPP Bureau - February 23, 2025
Among those identified, 2.4 lakh patients have been notified from public health institutions, while 1.1 lakh were identified through private healthcare facilities
Granules India acquires Swiss Senn Chemicals to foray into peptide and CDMO business
By IPP Bureau - February 22, 2025
The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
Aster DM Healthcare to invest Rs. 850 crore in next 3 years in Kerala
By IPP Bureau - February 22, 2025
Aster commits to increase bed capacity in the State via capacity expansion and greenfield projects
Zydus receives final approval from USFDA for Ibuprofen and Famotidine Tablets, 800 mg/26.6 mg
By IPP Bureau - February 22, 2025
Ibuprofen and famotidine combination is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis
Roche Diagnostics India screens 5,000 children for eye health
By IPP Bureau - February 21, 2025
Collaborates with VisionSpring to conduct eye check-up camps for underprivileged children
GSK's Nucala application for COPD accepted for review in China
By IPP Bureau - February 21, 2025
Around 100 million people live with COPD in China, accounting for almost 25% of all COPD cases globally
